Where Tech Meets Bio
Latest News
Tokyo-based Elix (founded 2016) has launched Elix Discovery, an AI drug discovery platform powered by federated learning models trained on proprietary compound data from 16 …
Read More
Google Expands MedGemma Collection With Multimodal Health AI Models for Open Development
Google Research has released two new models—MedGemma 27B Multimodal and MedSigLIP—as part of its open-source Health AI Developer Foundations (HAI-DEF) initiative, expanding the MedGemma suite …
Read More
Xaira Therapeutics Appoints Biotech Exec Behind Belharra and Ambys as President and COO to Scale AI-Driven Drug Discovery Platform
Xaira Therapeutics, the AI-native biotech launched in 2024 with over $1 billion in funding, has appointed biotech executive Jeff Jonker as President and Chief Operating …
Read More
Latest News
NIH To End Funding for Animal-Only Studies, Backing Shift to New Approach Methodologies
datma Launches Free Tool for Pharma to Assess Biomarker Coverage in Federated RWD
AbbVie Acquires Capstan Therapeutics for $2.1B, Gaining In Vivo CAR-T Platform Targeting Autoimmune Diseases
Chai Discovery Releases All-Atom Foundation Model for Zero-Shot Antibody Design with 16–20% Hit Rates
Arc Institute Opens Virtual Cell Challenge With $175K in AI Benchmarking Prizes
SandboxAQ Releases Public Database Containing 5.2 Million Synthetic Protein-Ligand Structures
Latest Insights
by Adele Ruder, Alexander Hustinx, Louise von Stechow
AI-Based Next-Generation-Phenotyping for Rare Disease Diagnosis
Rare diseases, which affect more than 300 million people worldwide, are often difficult to diagnose. Many patients wait five years or more for a correct …
Read More
by Andreas Dreps, Bea Mann, PhD
Combination Therapies May Be the Future of Oncology – How Can We Navigate Development Challenges Today?
The field of oncology is experiencing a proliferation of cancer therapies. In 2024 alone, the U.S. Food and Drug Administration (FDA) issued more than 60 …
Read More
Into the Unknown — How Artificial Intelligence Can Help Biotech Companies Chart the Dark Genome
by Louise von Stechow
AI-Based Next-Generation-Phenotyping for Rare Disease Diagnosis
by Adele Ruder, Alexander Hustinx, Louise von Stechow
How AI, Graphs, and GraphRAG Are Set to Revolutionize Alzheimer's Gene Research and Treatment
by Dominik Tomicevic
Novotech Report: Over 800 Global IPF Trials Since 2020, Led by Asia-Pacific
by BiopharmaTrend
Report: Nearly 80% of Life Sciences Leaders Considering Virtual Models for Observational Research
by BiopharmaTrend
AI in Drug Safety: From Concept to Reality, The Industry's Path Forward
by Dr. Karthik Muthusamy
Marking the Path Ahead: Integrating Oncology Biomarkers Into Clinical Development
by Bea Mann, PhD
Combination Therapies May Be the Future of Oncology – How Can We Navigate Development Challenges Today?
by Andreas Dreps, Bea Mann, PhD
From Our Partners
Sponsored by
OPTIC
AI Is Key to Democratizing Drug Discovery
Sponsored by
RECEPTOR.AI
This AI Startup Joins Forces With NVIDIA's BioNeMo to Boost Drug Discovery
Sponsored by
SpiroChem
Chemistry CROs at a Crossroads: How SpiroChem Is Adapting to Market Shifts in 2025 and Beyond
Sponsored by
Intelligencia AI
Patented AI Platform Identifies Promising Early-Stage BioPharma Assets and Companies
Partner Events

RNA Leaders USA Congress
Event Date: Sept. 10, 2025 - Sept. 11, 2025
Location: United States of America (Boston Exhibition & Convention Center)
Website: Link
Promo Code: MMBioPharmaTrend15
Read more ›››

Interactive Response Technologies 2025
Event Date: Oct. 14, 2025 - Oct. 15, 2025
Location: United States of America (The Westin Copley Place, Boston, MA)
Website: Link
Promo Code: IRT25BPT
Read more ›››

The 12th Aging Research & Drug Discovery Meeting
Event Date: Aug. 25, 2025 - Aug. 29, 2025
Location: Denmark (Ceremonial Hall, University of Copenhagen)
Website: Link
Case Studies
Sponsored by
Science Exchange
How Astellas Pharma Achieves R&D Operational Excellence with Science Exchange
Sponsored by
Celeris Therapeutics
Application of AI-driven Xanthos Platform for Designing Protein Degraders
Sponsored by
Kymera Therapeutics
Identifying High Impact Tissue Sparing E3 Ligases and Their Binders
Sponsored by
Bioz
Bioz Badges — Advanced Data-Widgets for Confident E-commerce
Sponsored by
RECEPTOR.AI
AI Becomes a Drop-in Replacement for Docking
Sponsored by
Arctoris
Using End-to-End Wet Lab Automation Combined with Machine Learning to Industrialize Drug Discovery
Sponsored by
RECEPTOR.AI
Busting the PoseBusters v3: AI Docking Software ArtiDock Beats Industry’s State of the Art in Speed and Accuracy
Sponsored by
Cyclica
Cyclica's Chemical Probes for DCAF1
Interviews
Navigating the Crossroads of AI and Oncology: A Deep Dive with Lantern Pharma's CEO, Panna Sharma
Democratizing Early Drug Discovery through Artificial Intelligence: Interview with Syntekabio CEO Jongsun Jung
Rethinking Clinical Trials: Tim Smith on Medable’s Approach to Speed and Efficiency
Cracking the Code of Life: An Interview with Stef van Grieken, CEO of Cradle, on AI-Driven Protein Engineering
Most Read
The CRO Industry in Flux: Navigating Technology, Business Models, and Trends in Pharma R&D Outsourcing
7 Promising RNA Biotech Companies To Watch in 2024
17 Companies Building the Future of Drug Development on a Chip
Insilico Medicine’s Generative AI Patent Provides Advantage in AI Drug Discovery Race